nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—Diplopia—Carmustine—melanoma	0.00339	0.029	CcSEcCtD
Oxprenolol—Bronchospasm—Bleomycin—melanoma	0.0033	0.0283	CcSEcCtD
Oxprenolol—Arthralgia—Vemurafenib—melanoma	0.00328	0.0281	CcSEcCtD
Oxprenolol—Diplopia—Temozolomide—melanoma	0.00327	0.0281	CcSEcCtD
Oxprenolol—Hypotension—Vemurafenib—melanoma	0.00294	0.0252	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00287	0.0246	CcSEcCtD
Oxprenolol—Sweating increased—Temozolomide—melanoma	0.00275	0.0236	CcSEcCtD
Oxprenolol—Fatigue—Vemurafenib—melanoma	0.00271	0.0233	CcSEcCtD
Oxprenolol—Hypersensitivity—Vemurafenib—melanoma	0.00232	0.0199	CcSEcCtD
Oxprenolol—Asthenia—Vemurafenib—melanoma	0.00226	0.0194	CcSEcCtD
Oxprenolol—Cardiac failure—Docetaxel—melanoma	0.00223	0.0191	CcSEcCtD
Oxprenolol—Pruritus—Vemurafenib—melanoma	0.00223	0.0191	CcSEcCtD
Oxprenolol—Diarrhoea—Vemurafenib—melanoma	0.00215	0.0185	CcSEcCtD
Oxprenolol—Dizziness—Vemurafenib—melanoma	0.00208	0.0178	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Docetaxel—melanoma	0.00199	0.017	CcSEcCtD
Oxprenolol—Headache—Vemurafenib—melanoma	0.00197	0.0169	CcSEcCtD
Oxprenolol—Nausea—Vemurafenib—melanoma	0.00187	0.016	CcSEcCtD
Oxprenolol—Thrombocytopenia—Bleomycin—melanoma	0.00187	0.016	CcSEcCtD
Oxprenolol—Bronchospasm—Docetaxel—melanoma	0.00185	0.0159	CcSEcCtD
Oxprenolol—Hypotension—Bleomycin—melanoma	0.00178	0.0153	CcSEcCtD
Oxprenolol—Palpitations—Temozolomide—melanoma	0.00174	0.0149	CcSEcCtD
Oxprenolol—Thrombocytopenia—Dactinomycin—melanoma	0.00174	0.0149	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Bleomycin—melanoma	0.00174	0.0149	CcSEcCtD
Oxprenolol—Arthralgia—Temozolomide—melanoma	0.00168	0.0144	CcSEcCtD
Oxprenolol—Thrombocytopenia—Carmustine—melanoma	0.00163	0.014	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00162	0.0139	CcSEcCtD
Oxprenolol—Thrombocytopenia—Temozolomide—melanoma	0.00157	0.0135	CcSEcCtD
Oxprenolol—Hypotension—Carmustine—melanoma	0.00155	0.0133	CcSEcCtD
Oxprenolol—Hyperhidrosis—Temozolomide—melanoma	0.00155	0.0133	CcSEcCtD
Oxprenolol—Fatigue—Dactinomycin—melanoma	0.00153	0.0131	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Carmustine—melanoma	0.00152	0.013	CcSEcCtD
Oxprenolol—Insomnia—Carmustine—melanoma	0.0015	0.0129	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Temozolomide—melanoma	0.00146	0.0126	CcSEcCtD
Oxprenolol—Insomnia—Temozolomide—melanoma	0.00145	0.0125	CcSEcCtD
Oxprenolol—Dyspepsia—Temozolomide—melanoma	0.00142	0.0121	CcSEcCtD
Oxprenolol—Abdominal pain—Dactinomycin—melanoma	0.00141	0.0121	CcSEcCtD
Oxprenolol—Hypersensitivity—Bleomycin—melanoma	0.0014	0.012	CcSEcCtD
Oxprenolol—Fatigue—Temozolomide—melanoma	0.00139	0.0119	CcSEcCtD
Oxprenolol—Asthenia—Bleomycin—melanoma	0.00137	0.0117	CcSEcCtD
Oxprenolol—Pruritus—Bleomycin—melanoma	0.00135	0.0116	CcSEcCtD
Oxprenolol—Abdominal pain—Carmustine—melanoma	0.00132	0.0113	CcSEcCtD
Oxprenolol—Hypersensitivity—Dactinomycin—melanoma	0.00131	0.0112	CcSEcCtD
Oxprenolol—Asthenia—Dactinomycin—melanoma	0.00128	0.0109	CcSEcCtD
Oxprenolol—Abdominal pain—Temozolomide—melanoma	0.00127	0.0109	CcSEcCtD
Oxprenolol—Hypersensitivity—Carmustine—melanoma	0.00123	0.0105	CcSEcCtD
Oxprenolol—Diarrhoea—Dactinomycin—melanoma	0.00122	0.0104	CcSEcCtD
Oxprenolol—Asthenia—Carmustine—melanoma	0.00119	0.0102	CcSEcCtD
Oxprenolol—Hypersensitivity—Temozolomide—melanoma	0.00118	0.0102	CcSEcCtD
Oxprenolol—Palpitations—Docetaxel—melanoma	0.00116	0.00993	CcSEcCtD
Oxprenolol—Asthenia—Temozolomide—melanoma	0.00115	0.00989	CcSEcCtD
Oxprenolol—Diarrhoea—Carmustine—melanoma	0.00114	0.00976	CcSEcCtD
Oxprenolol—Pruritus—Temozolomide—melanoma	0.00114	0.00976	CcSEcCtD
Oxprenolol—Nausea—Bleomycin—melanoma	0.00113	0.00971	CcSEcCtD
Oxprenolol—Arthralgia—Docetaxel—melanoma	0.00112	0.00957	CcSEcCtD
Oxprenolol—Dizziness—Carmustine—melanoma	0.0011	0.00944	CcSEcCtD
Oxprenolol—Diarrhoea—Temozolomide—melanoma	0.0011	0.00944	CcSEcCtD
Oxprenolol—Dizziness—Temozolomide—melanoma	0.00106	0.00912	CcSEcCtD
Oxprenolol—Nausea—Dactinomycin—melanoma	0.00106	0.00906	CcSEcCtD
Oxprenolol—Thrombocytopenia—Docetaxel—melanoma	0.00105	0.00898	CcSEcCtD
Oxprenolol—Headache—Carmustine—melanoma	0.00104	0.00894	CcSEcCtD
Oxprenolol—Headache—Temozolomide—melanoma	0.00101	0.00864	CcSEcCtD
Oxprenolol—Hypotension—Docetaxel—melanoma	0.000999	0.00857	CcSEcCtD
Oxprenolol—Nausea—Carmustine—melanoma	0.000988	0.00848	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Docetaxel—melanoma	0.000974	0.00835	CcSEcCtD
Oxprenolol—Insomnia—Docetaxel—melanoma	0.000967	0.00829	CcSEcCtD
Oxprenolol—Nausea—Temozolomide—melanoma	0.000955	0.00819	CcSEcCtD
Oxprenolol—Dyspepsia—Docetaxel—melanoma	0.000941	0.00807	CcSEcCtD
Oxprenolol—Fatigue—Docetaxel—melanoma	0.000922	0.00791	CcSEcCtD
Oxprenolol—Abdominal pain—Docetaxel—melanoma	0.000845	0.00725	CcSEcCtD
Oxprenolol—Hypersensitivity—Docetaxel—melanoma	0.000788	0.00676	CcSEcCtD
Oxprenolol—Asthenia—Docetaxel—melanoma	0.000767	0.00658	CcSEcCtD
Oxprenolol—Pruritus—Docetaxel—melanoma	0.000757	0.00649	CcSEcCtD
Oxprenolol—Diarrhoea—Docetaxel—melanoma	0.000732	0.00627	CcSEcCtD
Oxprenolol—Atenolol—ABCB1—melanoma	0.000717	0.323	CrCbGaD
Oxprenolol—Dizziness—Docetaxel—melanoma	0.000707	0.00606	CcSEcCtD
Oxprenolol—Headache—Docetaxel—melanoma	0.00067	0.00574	CcSEcCtD
Oxprenolol—Acebutolol—ABCB1—melanoma	0.000662	0.298	CrCbGaD
Oxprenolol—Nausea—Docetaxel—melanoma	0.000635	0.00545	CcSEcCtD
Oxprenolol—Metoprolol—ABCB1—melanoma	0.000559	0.252	CrCbGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PRKCA—melanoma	0.000502	0.00057	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EDN1—melanoma	0.000498	0.000565	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFC—melanoma	0.000497	0.000564	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—WNT5A—melanoma	0.000497	0.000564	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP17A1—melanoma	0.000491	0.000558	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTAP—melanoma	0.000489	0.000555	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EDN1—melanoma	0.000487	0.000552	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CSF2—melanoma	0.000486	0.000552	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—RAC1—melanoma	0.000476	0.00054	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CSF2—melanoma	0.000476	0.00054	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCA—melanoma	0.000466	0.000529	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—RAC1—melanoma	0.000466	0.000529	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNA11—melanoma	0.000464	0.000527	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCA—melanoma	0.000456	0.000518	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAP2K2—melanoma	0.000456	0.000517	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ALB—melanoma	0.000455	0.000516	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—FASN—melanoma	0.000454	0.000515	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC5A5—melanoma	0.000447	0.000507	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAP2K2—melanoma	0.000446	0.000506	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—F2R—melanoma	0.000446	0.000506	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—F2R—melanoma	0.000436	0.000495	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LUM—melanoma	0.000436	0.000495	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PHGDH—melanoma	0.000436	0.000495	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—RAC1—melanoma	0.000432	0.000491	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDNRB—melanoma	0.000432	0.00049	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNAQ—melanoma	0.000431	0.00049	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD44—melanoma	0.000431	0.00049	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HPSE—melanoma	0.000428	0.000485	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—RAC1—melanoma	0.000423	0.00048	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDNRB—melanoma	0.000422	0.000479	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—HRAS—melanoma	0.000421	0.000478	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CUBN—melanoma	0.00042	0.000476	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTK2B—melanoma	0.000419	0.000476	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP1B1—melanoma	0.000414	0.000469	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTK2B—melanoma	0.00041	0.000465	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNA11—melanoma	0.000408	0.000463	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAB2—melanoma	0.000408	0.000463	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FLT1—melanoma	0.000406	0.000461	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SDHD—melanoma	0.000405	0.00046	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BSG—melanoma	0.000405	0.00046	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CSPG4—melanoma	0.000405	0.00046	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CG—melanoma	0.000402	0.000456	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAB2—melanoma	0.000399	0.000453	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNA11—melanoma	0.000399	0.000453	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FLT1—melanoma	0.000397	0.000451	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CG—melanoma	0.000393	0.000447	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPAM—melanoma	0.000393	0.000446	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FOXO4—melanoma	0.000383	0.000435	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HDAC2—melanoma	0.000383	0.000435	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCR4—melanoma	0.000383	0.000435	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNAQ—melanoma	0.000379	0.00043	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FOXO4—melanoma	0.000375	0.000426	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HDAC2—melanoma	0.000375	0.000426	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCR4—melanoma	0.000375	0.000426	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNAQ—melanoma	0.000371	0.000421	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—melanoma	0.000365	0.000415	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—melanoma	0.000357	0.000405	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SYK—melanoma	0.000356	0.000405	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CD—melanoma	0.000354	0.000401	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT3—melanoma	0.00035	0.000397	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ITGAV—melanoma	0.00035	0.000397	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGFR—melanoma	0.00035	0.000397	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SYK—melanoma	0.000349	0.000396	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CD—melanoma	0.000346	0.000393	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGFR—melanoma	0.000342	0.000388	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ITGAV—melanoma	0.000342	0.000388	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT3—melanoma	0.000342	0.000388	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCB1—melanoma	0.000341	0.000387	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLA2G6—melanoma	0.000334	0.000379	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS1—melanoma	0.000324	0.000368	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAP2K1—melanoma	0.000323	0.000367	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—S100B—melanoma	0.000323	0.000367	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CD—melanoma	0.000321	0.000364	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS1—melanoma	0.000317	0.00036	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAP2K1—melanoma	0.000316	0.000359	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—S100B—melanoma	0.000316	0.000359	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CD—melanoma	0.000314	0.000356	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PRKCA—melanoma	0.000314	0.000356	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ERCC2—melanoma	0.000311	0.000353	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB4—melanoma	0.000309	0.000351	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CB—melanoma	0.000308	0.00035	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN2B—melanoma	0.000306	0.000348	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB4—melanoma	0.000302	0.000343	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CB—melanoma	0.000301	0.000342	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—VCAN—melanoma	0.0003	0.00034	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN2B—melanoma	0.0003	0.00034	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CD86—melanoma	0.000296	0.000336	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—melanoma	0.000296	0.000336	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDN1—melanoma	0.000294	0.000334	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CD86—melanoma	0.00029	0.000329	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—melanoma	0.00029	0.000329	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDN1—melanoma	0.000288	0.000326	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CSF2—melanoma	0.000287	0.000326	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF1—melanoma	0.000287	0.000326	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—IL2—melanoma	0.000283	0.000321	CbGpPWpGaD
Oxprenolol—Propranolol—ABCB1—melanoma	0.000282	0.127	CrCbGaD
Oxprenolol—ADRB1—Signaling Pathways—E2F1—melanoma	0.000281	0.000319	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF1—melanoma	0.000281	0.000319	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CSF2—melanoma	0.000281	0.000319	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CB—melanoma	0.00028	0.000318	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDGFRA—melanoma	0.000278	0.000316	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—IL2—melanoma	0.000277	0.000314	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ITGB3—melanoma	0.000275	0.000313	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCA—melanoma	0.000275	0.000313	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—E2F1—melanoma	0.000275	0.000312	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CB—melanoma	0.000274	0.000311	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDGFRA—melanoma	0.000272	0.000309	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SPP1—melanoma	0.00027	0.000307	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ITGB3—melanoma	0.000269	0.000306	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCA—melanoma	0.000269	0.000306	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAP2K2—melanoma	0.000269	0.000306	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—melanoma	0.000269	0.000305	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SPP1—melanoma	0.000264	0.0003	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAP2K2—melanoma	0.000263	0.000299	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—melanoma	0.000263	0.000299	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL2—melanoma	0.000257	0.000292	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TERT—melanoma	0.000256	0.000291	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RAC1—melanoma	0.000255	0.00029	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP17A1—melanoma	0.000253	0.000287	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL2—melanoma	0.000251	0.000285	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TERT—melanoma	0.000251	0.000284	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RAC1—melanoma	0.00025	0.000284	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—melanoma	0.000246	0.000279	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—melanoma	0.000245	0.000278	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—melanoma	0.00024	0.000272	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNA11—melanoma	0.000239	0.000271	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—melanoma	0.000237	0.000269	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—melanoma	0.000234	0.000266	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FASN—melanoma	0.000234	0.000265	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC5A5—melanoma	0.00023	0.000261	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—melanoma	0.000229	0.00026	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FN1—melanoma	0.000225	0.000256	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNAQ—melanoma	0.000222	0.000252	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD44—melanoma	0.000222	0.000252	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH1—melanoma	0.000221	0.00025	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FN1—melanoma	0.000221	0.00025	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CD80—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CD—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH1—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KIT—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APC—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NRAS—melanoma	0.000216	0.000245	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGF—melanoma	0.000213	0.000242	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—melanoma	0.000213	0.000242	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1B1—melanoma	0.000213	0.000242	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CD80—melanoma	0.000211	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—melanoma	0.000211	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APC—melanoma	0.000211	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KIT—melanoma	0.000211	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NRAS—melanoma	0.000211	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGF—melanoma	0.000209	0.000237	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK3—melanoma	0.000207	0.000235	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BRAF—melanoma	0.000203	0.00023	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK3—melanoma	0.000202	0.000229	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BRAF—melanoma	0.000198	0.000225	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—melanoma	0.000198	0.000224	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—MAPK1—melanoma	0.000197	0.000223	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—melanoma	0.000197	0.000223	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—melanoma	0.000193	0.000219	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—MAPK1—melanoma	0.000192	0.000218	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—melanoma	0.000192	0.000218	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAP2K1—melanoma	0.000191	0.000217	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CD—melanoma	0.00019	0.000215	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CB—melanoma	0.000188	0.000214	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—melanoma	0.000188	0.000213	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAP2K1—melanoma	0.000187	0.000212	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—melanoma	0.000186	0.000212	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KRAS—melanoma	0.000186	0.000211	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CD—melanoma	0.000186	0.000211	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—melanoma	0.000184	0.000209	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KRAS—melanoma	0.000182	0.000206	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF2—melanoma	0.000182	0.000206	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF2—melanoma	0.000178	0.000202	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCB1—melanoma	0.000175	0.000199	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—melanoma	0.000171	0.000194	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MDM2—melanoma	0.00017	0.000193	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB2—melanoma	0.000168	0.00019	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—melanoma	0.000167	0.000189	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MDM2—melanoma	0.000166	0.000189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CB—melanoma	0.000165	0.000188	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB2—melanoma	0.000164	0.000186	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTEN—melanoma	0.000163	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CB—melanoma	0.000162	0.000184	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PRKCA—melanoma	0.000161	0.000183	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ERCC2—melanoma	0.00016	0.000182	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—melanoma	0.000159	0.00018	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRAS—melanoma	0.000158	0.000179	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—melanoma	0.000155	0.000176	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1B—melanoma	0.000155	0.000176	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRAS—melanoma	0.000154	0.000175	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—melanoma	0.000153	0.000174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—melanoma	0.000152	0.000173	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL2—melanoma	0.000152	0.000172	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1B—melanoma	0.000152	0.000172	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—melanoma	0.000151	0.000171	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—melanoma	0.00015	0.00017	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—melanoma	0.000149	0.000169	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL2—melanoma	0.000149	0.000169	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—melanoma	0.000148	0.000168	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—melanoma	0.000148	0.000168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CTNNB1—melanoma	0.000147	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—melanoma	0.000145	0.000164	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—melanoma	0.000144	0.000163	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CTNNB1—melanoma	0.000143	0.000163	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1A—melanoma	0.000143	0.000163	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTEN—melanoma	0.000143	0.000162	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NFKB1—melanoma	0.000142	0.000161	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—melanoma	0.000141	0.00016	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1A—melanoma	0.00014	0.000159	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTEN—melanoma	0.00014	0.000159	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—melanoma	0.000139	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NFKB1—melanoma	0.000139	0.000158	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—melanoma	0.000136	0.000155	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—melanoma	0.000129	0.000146	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—melanoma	0.000128	0.000145	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NRAS—melanoma	0.000127	0.000145	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—melanoma	0.000126	0.000143	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—melanoma	0.000126	0.000143	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—melanoma	0.000125	0.000142	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NRAS—melanoma	0.000125	0.000142	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK3—melanoma	0.000122	0.000139	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—melanoma	0.000122	0.000138	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK3—melanoma	0.000119	0.000136	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—melanoma	0.000119	0.000135	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK1—melanoma	0.000116	0.000132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—melanoma	0.000116	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—melanoma	0.000116	0.000132	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—melanoma	0.000115	0.00013	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK1—melanoma	0.000114	0.000129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—melanoma	0.000114	0.000129	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CD—melanoma	0.000111	0.000126	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KRAS—melanoma	0.00011	0.000125	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—melanoma	0.00011	0.000125	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KRAS—melanoma	0.000107	0.000122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—melanoma	0.000101	0.000114	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—melanoma	9.86e-05	0.000112	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—melanoma	9.75e-05	0.000111	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CB—melanoma	9.69e-05	0.00011	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—melanoma	9.6e-05	0.000109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—melanoma	9.54e-05	0.000108	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—melanoma	9.37e-05	0.000106	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRAS—melanoma	9.33e-05	0.000106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRAS—melanoma	9.12e-05	0.000104	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—melanoma	8.93e-05	0.000101	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—melanoma	8.73e-05	9.91e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTEN—melanoma	8.37e-05	9.5e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—melanoma	8.23e-05	9.34e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—melanoma	8.05e-05	9.14e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—melanoma	5.9e-05	6.7e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—melanoma	4.82e-05	5.47e-05	CbGpPWpGaD
